Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Fulvestrant × Clear all

NCT03620643 2025-10-30

ROLo

Phase 2 Completed

33 enrolled 13 charts

BreastGastrointestinal

Stomach Neoplasms, Carcinoma, Lobular, Triple Negative Breast Neoplasms